AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report

A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player in the cancer-treatment industry. Its purchase of Medarex in July added a key drug for metastic melanoma that’s in Phase III trials. The drug has possible multiple indications – industry jargon for its ability to treat more…

Read Full News

BUSINESS BRIEFS August 3, 2026: Business news in the Berkshires and beyond

Belden House & Mews awarded Litchfield, Conn.— Belden House & Mews has received an Award of Merit from Preservation Connecticut in the 2026 Connecticut Preservation Awards, presented annually to recognize exceptional efforts to preserve and revitalize the state’s historic buildings, landscapes, and communities. Preservation stories often tell of threats and losses. With this in mind,…

Read Full News